Follow the people · Insider
Rebecca Chambers
Rebecca Chambers files insider transactions with the SEC as a chief financial officer of Veracyte (VCYT). We hold 3 disclosed purchases and sales filed since 17 March 2021, 1 of them in the last 90 days.
- Files forVCYT
- Disclosed buys and sells3 in all, 1 in the last 90 days
- Last disclosure4 September 2026
Positions held
4 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 19 July 2021 — 4 September 2026Chief Financial Officer · Veracyte (VCYT)54 Form 4 lines · source: SEC Form 4
- Filed 20 April 2026 — 20 April 2026Director · Alamar Biosciences (ALMR)2 Form 4 lines · source: SEC Form 4
- Filed 21 June 2021 — 19 February 2025Director · Inari Medical (NARI)7 Form 4 lines · source: SEC Form 4
- Filed 15 March 2021 — 24 June 2021Chief Financial Officer · Outset Medical (OM)17 Form 4 lines · source: SEC Form 4
Everything they disclosed
80 entries, newest first — one per disclosure report, one per Form 4 line- had shares withheld for tax on 3,603 shares of VeracyteSEC Form 44 September 2026Common Stock · traded 2 September 2026 · filed 4 September 2026
- ▼ sold on the open market 2,477 shares of VeracyteSEC Form 44 September 2026Common Stock · traded 4 September 2026 · filed 4 September 2026
- ▼ sold on the open market 1,175 shares of VeracyteSEC Form 44 September 2026Common Stock · traded 4 September 2026 · filed 4 September 2026
- had shares withheld for tax on 3,693 shares of VeracyteSEC Form 44 June 2026Common Stock · traded 2 June 2026 · filed 4 June 2026
- ▼ sold on the open market 1,600 shares of VeracyteSEC Form 44 June 2026Common Stock · traded 4 June 2026 · filed 4 June 2026
- ▼ sold on the open market 1,961 shares of VeracyteSEC Form 44 June 2026Common Stock · traded 4 June 2026 · filed 4 June 2026
- acquired or disposed of, other 140,612 shares of Alamar Biosciences (a derivative holding)SEC Form 420 April 2026Stock Option (Right to Buy) · traded 20 April 2026 · filed 20 April 2026
- acquired or disposed of, other 140,612 shares of Alamar Biosciences (a derivative holding)SEC Form 420 April 2026Stock Option (Right to Buy) · traded 20 April 2026 · filed 20 April 2026
- was granted 36,181 shares of VeracyteSEC Form 410 March 2026Common Stock · traded 6 March 2026 · filed 10 March 2026
- was granted 13,157 shares of VeracyteSEC Form 410 March 2026Common Stock · traded 6 March 2026 · filed 10 March 2026
- was granted 36,181 shares of VeracyteSEC Form 410 March 2026Common Stock · traded 6 March 2026 · filed 10 March 2026
- was granted 13,157 shares of VeracyteSEC Form 410 March 2026Common Stock · traded 6 March 2026 · filed 10 March 2026
- ▼ sold on the open market 4,400 shares of VeracyteSEC Form 46 March 2026Common Stock · traded 4 March 2026 · filed 6 March 2026
- ▼ sold on the open market 13,941 shares of VeracyteSEC Form 46 March 2026Common Stock · traded 4 March 2026 · filed 6 March 2026
- ▼ sold on the open market 4,400 shares of VeracyteSEC Form 46 March 2026Common Stock · traded 4 March 2026 · filed 6 March 2026
- ▼ sold on the open market 13,941 shares of VeracyteSEC Form 46 March 2026Common Stock · traded 4 March 2026 · filed 6 March 2026
- had shares withheld for tax on 7,234 shares of VeracyteSEC Form 44 March 2026Common Stock · traded 2 March 2026 · filed 4 March 2026
- had shares withheld for tax on 7,234 shares of VeracyteSEC Form 44 March 2026Common Stock · traded 2 March 2026 · filed 4 March 2026
- was granted 59,324 shares of VeracyteSEC Form 42 March 2026Common Stock · traded 26 February 2026 · filed 2 March 2026
- had shares withheld for tax on 12,049 shares of VeracyteSEC Form 42 March 2026Common Stock · traded 26 February 2026 · filed 2 March 2026
- was granted 59,324 shares of VeracyteSEC Form 42 March 2026Common Stock · traded 26 February 2026 · filed 2 March 2026
- had shares withheld for tax on 12,049 shares of VeracyteSEC Form 42 March 2026Common Stock · traded 26 February 2026 · filed 2 March 2026
- had shares withheld for tax on 3,384 shares of VeracyteSEC Form 44 December 2025Common Stock · traded 2 December 2025 · filed 4 December 2025
- ▼ sold on the open market 8,537 shares of VeracyteSEC Form 44 December 2025Common Stock · traded 4 December 2025 · filed 4 December 2025
- ▼ sold on the open market 4,741 shares of VeracyteSEC Form 44 December 2025Common Stock · traded 4 December 2025 · filed 4 December 2025
- ▼ sold on the open market 7,000 shares of VeracyteSEC Form 47 November 2025Common Stock · traded 5 November 2025 · filed 7 November 2025
- had shares withheld for tax on 5,371 shares of VeracyteSEC Form 44 September 2025Common Stock · traded 2 September 2025 · filed 4 September 2025
- had shares withheld for tax on 5,370 shares of VeracyteSEC Form 44 June 2025Common Stock · traded 2 June 2025 · filed 4 June 2025
- was granted 30,200 shares of VeracyteSEC Form 410 March 2025Common Stock · traded 6 March 2025 · filed 10 March 2025
- was granted 23,170 shares of VeracyteSEC Form 43 March 2025Common Stock · traded 27 February 2025 · filed 3 March 2025
- had shares withheld for tax on 11,911 shares of VeracyteSEC Form 43 March 2025Common Stock · traded 27 February 2025 · filed 3 March 2025
- had shares withheld for tax on 11,070 shares of VeracyteSEC Form 43 March 2025Common Stock · traded 2 March 2025 · filed 3 March 2025
- disposed of in a tender offer 9,684 shares of Inari MedicalSEC Form 419 February 2025Common Stock · traded 19 February 2025 · filed 19 February 2025
- ▼ sold on the open market 527 shares of VeracyteSEC Form 45 February 2025Common Stock · traded 3 February 2025 · filed 5 February 2025
- had shares withheld for tax on 3,464 shares of VeracyteSEC Form 44 December 2024Common Stock · traded 2 December 2024 · filed 4 December 2024
- ▼ sold on the open market 7,000 shares of VeracyteSEC Form 44 December 2024Common Stock · traded 3 December 2024 · filed 4 December 2024
- ▼ sold on the open market 15,275 shares of VeracyteSEC Form 414 November 2024Common Stock · traded 12 November 2024 · filed 14 November 2024
- had shares withheld for tax on 3,464 shares of VeracyteSEC Form 44 September 2024Common Stock · traded 2 September 2024 · filed 4 September 2024
- ▼ sold on the open market 260 shares of Inari MedicalSEC Form 424 June 2024Common Stock · traded 21 June 2024 · filed 24 June 2024
- had shares withheld for tax on 3,462 shares of VeracyteSEC Form 44 June 2024Common Stock · traded 2 June 2024 · filed 4 June 2024
- ▼ sold on the open market 964 shares of Inari MedicalSEC Form 421 May 2024Common Stock · traded 20 May 2024 · filed 21 May 2024
- was granted 4,126 shares of Inari MedicalSEC Form 426 April 2024Common Stock · traded 24 April 2024 · filed 26 April 2024
- was granted 4,318 shares of VeracyteSEC Form 419 March 2024Common Stock · traded 15 March 2024 · filed 19 March 2024
- had shares withheld for tax on 2,189 shares of VeracyteSEC Form 419 March 2024Common Stock · traded 15 March 2024 · filed 19 March 2024
- was granted 59,856 shares of VeracyteSEC Form 48 March 2024Common Stock · traded 6 March 2024 · filed 8 March 2024
- had shares withheld for tax on 6,112 shares of VeracyteSEC Form 45 March 2024Common Stock · traded 2 March 2024 · filed 5 March 2024
- had shares withheld for tax on 1,800 shares of VeracyteSEC Form 45 December 2023Common Stock · traded 2 December 2023 · filed 5 December 2023
- had shares withheld for tax on 3,652 shares of VeracyteSEC Form 46 September 2023Common Stock · traded 2 September 2023 · filed 6 September 2023
- had shares withheld for tax on 1,183 shares of VeracyteSEC Form 46 June 2023Common Stock · traded 2 June 2023 · filed 6 June 2023
- was granted 2,412 shares of Inari MedicalSEC Form 419 May 2023Common Stock · traded 18 May 2023 · filed 19 May 2023
- was granted 42,956 shares of Veracyte (a derivative holding)SEC Form 49 March 2023Stock Option (right to buy) · traded 6 March 2023 · filed 9 March 2023
- was granted 26,014 shares of VeracyteSEC Form 49 March 2023Common Stock · traded 6 March 2023 · filed 9 March 2023
- had shares withheld for tax on 2,726 shares of VeracyteSEC Form 43 March 2023Common Stock · traded 2 March 2023 · filed 3 March 2023
- had shares withheld for tax on 735 shares of VeracyteSEC Form 46 December 2022Common Stock · traded 2 December 2022 · filed 6 December 2022
- had shares withheld for tax on 3,023 shares of VeracyteSEC Form 47 September 2022Common Stock · traded 2 September 2022 · filed 7 September 2022
- was granted 36,496 shares of Veracyte (a derivative holding)SEC Form 49 August 2022Common Stock · traded 5 August 2022 · filed 9 August 2022
- was granted 21,404 shares of VeracyteSEC Form 49 August 2022Common Stock · traded 5 August 2022 · filed 9 August 2022
- was granted 2,420 shares of Inari MedicalSEC Form 427 May 2022Common Stock · traded 26 May 2022 · filed 27 May 2022
- was granted 37,773 shares of Veracyte (a derivative holding)SEC Form 47 March 2022Stock Option (right to buy) · traded 3 March 2022 · filed 7 March 2022
- was granted 20,728 shares of VeracyteSEC Form 47 March 2022Common Stock · traded 3 March 2022 · filed 7 March 2022
- was granted 34,000 shares of VeracyteSEC Form 420 July 2021Common Stock · traded 19 July 2021 · filed 20 July 2021
- was granted 67,000 shares of Veracyte (a derivative holding)SEC Form 420 July 2021Stock Option (right to buy) · traded 19 July 2021 · filed 20 July 2021
- exercised options over 16,727 shares of Outset MedicalSEC Form 425 June 2021Common Stock · traded 24 June 2021 · filed 25 June 2021
- ▼ sold on the open market 16,727 shares of Outset MedicalSEC Form 425 June 2021Common Stock · traded 24 June 2021 · filed 25 June 2021
- exercised options over 16,727 shares of Outset Medical (a derivative holding)SEC Form 425 June 2021Non-Qualified Stock Option (right to buy) · traded 24 June 2021 · filed 25 June 2021
- was granted 1,950 shares of Inari MedicalSEC Form 422 June 2021Common Stock · traded 21 June 2021 · filed 22 June 2021
- exercised options over 16,727 shares of Outset MedicalSEC Form 426 May 2021Common Stock · traded 25 May 2021 · filed 26 May 2021
- ▼ sold on the open market 16,727 shares of Outset MedicalSEC Form 426 May 2021Common Stock · traded 25 May 2021 · filed 26 May 2021
- exercised options over 16,727 shares of Outset Medical (a derivative holding)SEC Form 426 May 2021Non-Qualified Stock Option (right to buy) · traded 25 May 2021 · filed 26 May 2021
- exercised options over 16,727 shares of Outset MedicalSEC Form 428 April 2021Common Stock · traded 27 April 2021 · filed 28 April 2021
- ▼ sold on the open market 8,499 shares of Outset MedicalSEC Form 428 April 2021Common Stock · traded 27 April 2021 · filed 28 April 2021
- ▼ sold on the open market 8,228 shares of Outset MedicalSEC Form 428 April 2021Common Stock · traded 27 April 2021 · filed 28 April 2021
- exercised options over 16,727 shares of Outset Medical (a derivative holding)SEC Form 428 April 2021Stock Option (Right to Buy) · traded 27 April 2021 · filed 28 April 2021
- exercised options over 16,727 shares of Outset Medical (a derivative holding)SEC Form 429 March 2021Stock Option (Right to Buy) · traded 25 March 2021 · filed 29 March 2021
- exercised options over 16,727 shares of Outset MedicalSEC Form 429 March 2021Common Stock · traded 25 March 2021 · filed 29 March 2021
- ▼ sold on the open market 3,592 shares of Outset MedicalSEC Form 429 March 2021Common Stock · traded 25 March 2021 · filed 29 March 2021
- ▼ sold on the open market 13,135 shares of Outset MedicalSEC Form 429 March 2021Common Stock · traded 25 March 2021 · filed 29 March 2021
- was granted 27,037 shares of Outset Medical (a derivative holding)SEC Form 418 March 2021Stock Option (Right to Buy) · traded 15 March 2021 · filed 18 March 2021
- was granted 13,597 shares of Outset MedicalSEC Form 417 March 2021Common Stock · traded 15 March 2021 · filed 17 March 2021
- was granted 27,037 shares of Outset Medical (a derivative holding)SEC Form 417 March 2021Stock Option (Right to Buy) · traded 15 March 2021 · filed 17 March 2021
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.